Peripheral Neuropathy in the Phase 3 ASPEN Study of Bruton Tyrosine Kinase Inhibitors for Waldenström Macroglobulinemia.
Heyman BM, Opat SS, Wahlin BE, Dimopoulos MAA, Castillo JJ, Tedeschi A, Tam CS, Buske C, Owen RG, Leblond V, Trotman J, Barnes G, Chan WY, Schneider J, Allewelt H, Cohen AC, Matous JV.
Heyman BM, et al. Among authors: barnes g.
Blood Adv. 2024 Dec 3:bloodadvances.2024014115. doi: 10.1182/bloodadvances.2024014115. Online ahead of print.
Blood Adv. 2024.
PMID: 39626287